The FDA has approved a new medication for grass allergies.
Spring is finally here, with the cold weather giving way to blooming plants and flowers. With spring comes seasonal allergies, with itchy eyes and runny noses being brought on by the increased pollen count and exposure to outdoor elements. Signaling a shift in how symptoms are treated, the U.S. Food and Drug Administration (FDA) recently approved a new pill that would help individuals fight grass allergies.
According to the FDA, more than 30 million people in the United States – and 500 million globally – have the type of allergy that is commonly referred to as hay fever. Although there is no real cure for this affliction, it can be managed by taking medication to fight the symptoms or receiving a shot to reduce sensitivity. With the new pill that has been approved, Oralair, patients will be exposed directly to what makes them sick in order for their bodies to build up an immunity.
While this pill has been used for several years in Europe to combat grass allergies, it is the first of its kind in the United States. By approving a type of sublingual therapy – exposing the person to allergens directly through this medication – the FDA is opening the door for further advancements in allergy treatments. This treatment can, in very rare cases, cause a severe allergic reaction, so health officials recommend taking it for the first time under the supervision of a doctor.
Individuals who suffer from seasonal allergies should invest in a home air purifier from US Air Purifiers Direct 2U. We have a wide selection of affordable air purifiers for customers to choose from, which can help alleviate your symptoms.